Advanced search
Publication Cover
Climacteric Volume 27, 2024 - Issue 1: Special Issue: Cardiovascular disease in women
Submit an article Journal homepage
809
Views
0
CrossRef citations to date
0
Altmetric
Editorials

Cardiovascular disease in women: take it to heart

Cynthia A. StuenkelDepartment of Medicine, Division of Endocrinology and Metabolism, UC San Diego School of Medicine, La Jolla, CA, USACorrespondence[email protected]
(GUEST EDITOR)
Pages 2-4 | Published online: 15 Jan 2024

References

  • World Heart Federation. Women & CVD. Available at https://world-heart-federation.org/what-we-do/women-cvd/; accessed 6/24/23.
  • Vogel B, Acevedo M, Appelman Y, et al. The Lancet women and cardiovascular disease Commission: reducing the global burden by 2030. Lancet. 2021 Jun 19;397(10292):2385–2438. Epub 2021 May 16. PMID: 34010613. doi: 10.1016/S0140-6736(21)00684-X.
  • Wenger NK, Lloyd-Jones DM, Elkind MSV, et al. American Heart Association. Call to Action for Cardiovascular Disease in Women: Epidemiology, Awareness, Access, and Delivery of Equitable Health Care: A Presidential Advisory From the American Heart Association. Circulation. 2022 Jun 7;145(23):e1059–e1071. doi: 10.1161/CIR.0000000000001071.
  • Stuenkel CA. Reproductive milestones across the lifespan and cardiovascular disease risk in women. Climacteric. 2023 Sep 28:1–11. Epub ahead of print. PMID: 37769699. doi: 10.1080/13697137.2023.2259793.
  • Nathani M, Vogel B, Mehran R. Closing the gap: cardiovascular disease in women. Climacteric. 2023. Epub ahead of print. doi: 10.1080/13697137.2023.2281935.
  • Patel N, Greene N, Guynn N, et al. Ischemia but no obstructive coronary artery disease: more than meets the eye. Climacteric. 2023. Epub ahead of print. doi: 10.1080/13697137.2023.2281933.
  • Spacht WA, Lau ES. A disease of her own? Unique features of heart failure in women. Climacteric. 2023 Sep 28:1–9. Epub ahead of print. PMID: 37768321. doi: 10.1080/13697137.2023.2256673.
  • Mikkola TS, Ylikorkala O. Pregnancy-associated risk factors for future cardiovascular disease – early prevention strategies warranted. Climacteric. 2023. Epub ahead of print. doi: 10.1080/13697137.2023.2287628.
  • Benham JL, Goldberg A, Teede H, Tay CT. Polycystic ovary syndrome: associations with cardiovascular risk. Climacteric. 2023. Epub ahead of print. doi: 10.1080/13697137.2023.2282689.
  • Davis SR. Testosterone and the heart: friend or foe? Climacteric. 2023 Sep 4:1–7. Epub ahead of print. PMID: 37666273. doi: 10.1080/13697137.2023.2250252.
  • Ray M, Butel-Simoes LE, Lombard JM, et al. Women’s cardiovascular health – the cardio-oncologic jigsaw. Climacteric. 2023. Epub ahead of print. doi: 10.1080/13697137.2023.2286382.
  • Lambrinoudaki I, Armeni E. Understanding of and clinical approach to cardiometabolic transition at the menopause. Climacteric. 2023 May 24:1–7. Epub ahead of print. PMID: 37224871. doi: 10.1080/13697137.2023.2202809.
  • Thurston RC. Vasomotor symptoms and cardiovascular health: findings from the SWAN and the MsHeart/MsBrain studies. Climacteric. 2023 Aug 14:1–6. Epub ahead of print. PMID: 37577812. doi: 10.1080/13697137.2023.2196001.
  • Nudy M, Buerger J, Dreibelbis S, et al. Menopausal hormone therapy and coronary heart disease: the roller coaster history. Climacteric. 2023. Epub ahead of print. doi: 10.1080/13697137.2023.2282690.
  • Maas AHEM. Cardiovascular risk assessment in women: which women are suited for menopausal hormone therapy? Climacteric. 2023 Nov 6:1–4. Epub ahead of print. PMID: 37931647. doi: 10.1080/13697137.2023.2259799.
  • Bontempo S, Yeganeh L, Giri R, Vincent AJ. Use of MHT in women with cardiovascular disease: a systematic review and meta-analysis. Climacteric. 2023 Nov 7:1–11. Epub ahead of print. PMID: 37933495. doi: 10.1080/13697137.2023.2273524.
  • Gray MP, Vogel B, Mehran R, et al. Primary prevention of cardiovascular disease in women. Climacteric. 2023. Epub ahead of print. doi: 10.1080/13697137.2023.2282685.
  • International Go Red for Women. Available at: https://www.goredforwomen.org/en/about-go-red-for-women/international; ©2023 American Heart Association; Accessed 6 Nov 2023.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.